In this episode, Allen Page, DVM, PhD, joined us to discuss some of his research on the metabolic effects of various intra-articular corticosteroids, as well as how ertugliflozin may influence horses’ metabolic responses to these treatments. Page spoke about how differences among corticosteroids can inform veterinarians’ choices when selecting intra-articular agents, key considerations when using SGLT2 inhibitors in horses that require joint injections, the limitations of the current research, and more.
This episode of Disease Du Jour is brought to you by Equithrive.
Podden och tillhörande omslagsbild på den här sidan tillhör
Disease DuJour. Innehållet i podden är skapat av Disease DuJour och inte av,
eller tillsammans med, Poddtoppen.
